Genotoxicity testing is very crucial to determine potential carcinogenic or mutagenic compounds that can cause genetic alterations in cells.

Genetic toxicology analysis are intended to identify medications that have the potential to directly or indirectly harm genetic material through a variety of methods.

Services:

» Micronucleus Assay
» COMET Assay
» Fluorescence In Situ Hybridization (FISH)
» AMES Analysis
» Chromosomal Aberration Assay (CA)

When compounds are found to be genotoxic in these assays, they may be mutagens or human carcinogens, which could lead to cancer and/or heritable abnormalities.

Numerous oncological and genetic illnesses are among the disease signs that researchers have been able to connect to the mutations brought on by genetic toxicity.

- Diagnosing genetic disorders
- Monitoring cancer and precancerous changes
- Assessing disease progression or treatment response
- Screening for chromosomal instability syndromes

These services provide essential support for research, drug discovery, toxicity testing, and various other biomedical applications. Outsourcing these services allows organizations to access specialized technical expertise, state-of-the-art facilities, and standardized protocols.

Note : Our custom analysis will provide valid solutions and guarantee a high-quality report for your research. Kindly share the technical details of work for quotation and lead time.

+ 91 9891 179928                 info@allelelifesciences.com